Itron officer David M. Wright proposes $10K share sale
The notice identifies restricted stock vesting as the source of the shares and lists two earlier sales by Wright in August 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Itron, Inc. officer David M. Wright reported a proposed sale of 100 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $10,008.03 and a proposed sale date of November 2, 2026. The shares were acquired from the issuer through restricted stock vesting on August 23, 2025. Wright also reported sales of 58 shares on August 20, 2026, for $5,673.90, and 76 shares on August 24, 2026, for $7,508.04.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.